Association of genetic variants with chronic kidney disease in Japanese individuals with or without hypertension or diabetes mellitus

Yoshida,Tetsuro; Kato,Kimihiko; Yokoi,Kiyoshi; Oguri,Mitsutoshi; Watanabe,Sachiro; Metoki,Norifumi; Yoshida,Hidemi; Satoh,Kei; Aoyagi,Yukitoshi; Nozawa,Yoshinori; Yamada,Yoshiji

doi:10.3892/etm_00000023

Association of genetic variants with chronic kidney disease in Japanese individuals with or without hypertension or diabetes mellitus

Authors:
- Tetsuro Yoshida
- Kimihiko Kato
- Kiyoshi Yokoi
- Mitsutoshi Oguri
- Sachiro Watanabe
- Norifumi Metoki
- Hidemi Yoshida
- Kei Satoh
- Yukitoshi Aoyagi
- Yoshinori Nozawa
- Yoshiji Yamada
View Affiliations

Affiliations: Department of Cardiovascular Medicine, Inabe General Hospital, Inabe, Japan
Published online on: January 1, 2010 https://doi.org/10.3892/etm_00000023
Pages: 137-145

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hypertension and diabetes mellitus are important risk factors for chronic kidney disease (CKD). The purpose of the present study was to identify genetic variants that confer susceptibility to CKD in individuals with or without hypertension or diabetes mellitus, thereby contributing to the personalized prevention of CKD in such individuals separately. The study population comprised 5835 unrelated Japanese individuals, including 1763 subjects with CKD and 4072 controls. The 150 polymorphisms were selected by genome-wide association studies of ischemic stroke and myocardial infarction with the use of the GeneChip Human Mapping 500K Array Set (Affymetrix). The genotypes for these polymorphisms were determined by a method that combines polymerase chain reaction and sequence-specific oligonucleotide probes with suspension array technology. The χ2 test, multivariable logistic regression analysis with adjustment for covariates, as well as a stepwise forward selection procedure revealed that two different polymorphisms were significantly (P<0.005) associated with the prevalence of CKD in individuals with or without hypertension or diabetes mellitus: the A↷G (Lys625Arg) polymorphism of CDH4 (rs6142884) in individuals without diabetes mellitus, and the C↷T polymorphism of PTPRN2 (rs1638021) in individuals with hypertension and diabetes mellitus. No polymorphism was significantly associated with CKD in individuals with or without hypertension, in those with diabetes mellitus, or in those without hypertension or diabetes mellitus. Stratification of subjects based on hypertension or diabetes mellitus may thus be fundamental to achieving the personalized prevention of CKD with the use of genetic information.

View Figures

View References

1.	Foley RN, Parfrey PS and Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 32:112–119. 1998. View Article : Google Scholar : PubMed/NCBI
2.	Go AS, Chertow GM, Fan D, McCulloch CE and Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. N Engl J Med. 351:1296–1305. 2004. View Article : Google Scholar : PubMed/NCBI
3.	Ruilope LM, Salvetti A, Jamerson K, et al: Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol. 12:218–225. 2001.PubMed/NCBI
4.	National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 39:1–266. 2002.PubMed/NCBI
5.	Gharavi AG, Yan Y, Scolari F, et al: IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22–23. Nat Genet. 26:354–357. 2000.PubMed/NCBI
6.	Hanson RL, Craig DW and Millis MP: Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study. Diabetes. 56:975–983. 2007. View Article : Google Scholar
7.	Doi K, Noiri E, Nakao A, Fujita T, Kobayashi S and Tokunaga K: Functional polymorphisms in the vascular endothelial growth factor gene are associated with development of end-stage renal disease in males. J Am Soc Nephrol. 17:823–830. 2006. View Article : Google Scholar : PubMed/NCBI
8.	Wetmore JB, Hung AM, Lovett DH, Sen S, Quershy O and Johansen KL: Interleukin-1 gene cluster polymorphisms predict risk of ESRD. Kidney Int. 68:278–284. 2005. View Article : Google Scholar : PubMed/NCBI
9.	Yoshida T, Kato K, Fujimaki T, et al: Association of a polymorphism of the apolipoprotein E gene with chronic kidney disease in Japanese individuals with metabolic syndrome. Genomics. 93:221–226. 2009. View Article : Google Scholar : PubMed/NCBI
10.	Yoshida T, Kato K, Yokoi K, et al: Association of genetic variants with chronic kidney disease in Japanese individuals with type 2 diabetes mellitus. Int J Mol Med. 23:529–537. 2009.PubMed/NCBI
11.	Yoshida T, Kato K, Yokoi K, et al: Association of candidate gene polymorphisms with chronic kidney disease in Japanese individuals with hypertension. Hypertens Res. 32:411–418. 2009. View Article : Google Scholar : PubMed/NCBI
12.	Yoshida T, Kato K, Yokoi K, et al: Association of genetic variants with chronic kidney disease in individuals with different lipid profiles. Int J Mol Med. 24:2332462009.PubMed/NCBI
13.	Matsuo S, Imai E, Horio M, et al: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 53:982–992. 2009. View Article : Google Scholar : PubMed/NCBI
14.	Yamada Y, Fuku N, Tanaka M, et al: Identification of CELSR1 as a susceptibility gene for ischemic stroke in Japanese individuals by a genome-wide association study. Atherosclerosis: E-pub ahead of print,. 2009. View Article : Google Scholar : PubMed/NCBI
15.	Yoshida T, Kato K, Fujimaki T, et al: Association of genetic variants with chronic kidney disease in Japanese individuals. Clin J Am Soc Nephrol. 4:883–890. 2009. View Article : Google Scholar : PubMed/NCBI
16.	Yoshida T, Kato K, Yokoi K, et al: Association of gene polymorphisms with chronic kidney disease in high-risk or low-risk subjects defined by conventional risk factors. Int J Mol Med. 23:785–792. 2009.PubMed/NCBI
17.	Itoh Y, Mizuki N, Shimada T, et al: High-throughput DNA typing of HLA-A, -B, -C and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics. 57:717–729. 2005. View Article : Google Scholar : PubMed/NCBI
18.	Suzuki S, Sano K and Tanihara H: Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue. Cell Regul. 2:261–270. 1991.PubMed/NCBI
19.	Miotto E, Sabbioni S, Veronese A, et al: Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer. Cancer Res. 64:8156–8159. 2004. View Article : Google Scholar : PubMed/NCBI
20.	Obst-Pernberg K, Medina L and Redies C: Expression of R-cadherin and N-cadherin by cell groups and fiber tracts in the developing mouse forebrain: relation to the formation of functional circuits. Neuroscience. 106:505–533. 2001. View Article : Google Scholar : PubMed/NCBI
21.	Cavodeassi F, Carreira-Barbosa F, Young RM, et al: Early stages of zebrafish eye formation require the coordinated activity of Wnt11, Fz5 and the Wnt/beta-catenin pathway. Neuron. 47:43–56. 2005. View Article : Google Scholar : PubMed/NCBI
22.	Wasmeier C and Hutton JC: Molecular cloning of phogrin, a protein-tyrosine phosphatase homologue localized to insulin secretory granule membranes. J Biol Chem. 271:18161–18170. 1996. View Article : Google Scholar : PubMed/NCBI
23.	Kawasaki E, Hutton JC and Eisenbarth GS: Molecular cloning and characterization of the human transmembrane protein tyrosine phosphatase homologue, phogrin, an autoantigen of type 1 diabetes. Biochem Biophys Res Commun. 227:440–447. 1996. View Article : Google Scholar
24.	Orth SR: Smoking and the kidney. J Am Soc Nephrol. 13:1663–1672. 2002. View Article : Google Scholar : PubMed/NCBI